News › Clinical Practice, Industry News, Patient Care

FDA alerts more doctors of rare cancer with breast implants

February 15, 2019

U.S. health officials are telling doctors to be on the lookout for a rare cancer linked to breast implants after receiving more reports of the disease.
The Food and Drug Administration sent a letter Wednesday to family doctors, nurses and other health professionals warning about the form of lymphoma that affects breast implant patients. In suspected cases, the FDA recommends laboratory testing to confirm or rule out of the disease. It’s the first time regulators have issued a direct warning to doctors other than plastic surgeons.
Read more at WNCT9 >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Cold Laser Therapy: The Science and Uses for Med Spas
    • Compounded Tirzepatide, NAD+ Injections Recalled Nationwide Over Sterility Concerns
    • Meliora Consulting Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
Advertisement